DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/hhg4s5/hemoglobin_a1c) has announced the addition of the "Hemoglobin A1c ...
Neonatal hyperbilirubinemia is common, with significant elevations resulting in long-term neurological impairments or death, if untreated. Hospital-based analyzers are the gold standard for measuring ...
Genetic testing to inform on medication decisions has transformed from an expensive option only available in select academic settings to something that can be performed in most clinical practices by ...
A novel nanobody-based immunosensor, designed to function stably in undiluted biological fluids and harsh conditions, has been developed. Their innovative design leverages BRET -- bioluminescence ...
In a study published today in Biofunctional Materials, Prof. Dr. Haidar, Founder and CEO of BioMAT’X I+D+I LABs in Santiago, Chile, explores a new era in healthcare diagnostics driven by ...
Researchers from the University of Stellenbosch in South Africa are seeking protection for a simple and user-friendly point-of-care device for diagnosing tuberculosis. Their electrochemical lateral ...
This pilot study evaluates a newly developed point-of-care (PoC) device designed to measure bilirubin levels in human blood serum using a microfluidic cartridge and optoelectronic sensing module.
This blog was written by Simran Goyal, a fourth year medical student at the University of Cambridge. Simran was on placement for her Student Selected Component (SSC) with us between 10 December 2018 ...
Correlation between the blue and green sensor channel outputs measured by the PoC device; (A) All the samples collected in this study; (B) Single patient highlighted by the yellow circle in (A). This ...
Point of care testing in the emergency department: Finding comprehensive solutions that work for you
Speed and precision are two of the most vital considerations when it comes to patient care in the high-stakes environment of the Emergency Department (ED). Thus, swift decision-making and accurate ...
In what represents its first patenting, San Diego-based Intrigue Health Inc. seeks protection for a diagnostic kit that its inventors say will bring clinical laboratory quality testing directly into ...
This was a pilot-controlled trial carried out among 72 patients (34 cases and 38 controls) in southwestern Nigeria. The cases were those with histopathological diagnosis of CRC while controls were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results